+1 (704) 266-3234

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Insights And Forecast To 2028

Published on: Apr 2022 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 99

Non-steroidal Anti-inflammatory Drugs (NSAID) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Non-steroidal Anti-inflammatory Drugs (NSAID) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
Segment by Application
Human
Animals
Others
By Company
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

1 Study Coverage
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Introduction
1.2 Market by Type
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Salicylates
1.2.3 Propionic acid derivatives
1.2.4 Acetic acid derivatives
1.2.5 Enolic acid (Oxicam) derivatives
1.2.6 Anthranilic acid derivatives (Fenamates)
1.2.7 Selective COX-2 inhibitors (Coxibs)
1.2.8 Sulfonanilides
1.3 Market by Application
1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Human
1.3.3 Animals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Estimates and Forecasts 2017-2028
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Estimates and Forecasts 2017-2028
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region
2.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022)
2.4.2 Global Sales Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2023-2028)
2.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region
2.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022)
2.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers
3.1.1 Global Top Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers by Sales (2017-2022)
3.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) in 2021
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers
3.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2017-2022)
3.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2021
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type
4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Sales by Type (2017-2022)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Sales by Type (2023-2028)
4.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type
4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Revenue by Type (2017-2022)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type
4.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2022)
4.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application
5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Sales by Application (2017-2022)
5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Sales by Application (2023-2028)
5.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application
5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Revenue by Application (2017-2022)
5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application
5.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2022)
5.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
6.1.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
6.1.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
6.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
6.2.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
6.2.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
6.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
6.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
6.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
7.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
7.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
7.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
7.2.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
7.2.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
7.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
7.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
7.3.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
8.1.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
8.1.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
8.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
8.2.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
8.2.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
8.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region
8.3.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2028)
8.3.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
9.1.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
9.1.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
9.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
9.2.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
9.2.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
9.3 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
9.3.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
9.3.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
10.1.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
10.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
10.2.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
10.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
10.3.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Ecotrin
11.2.1 Ecotrin Corporation Information
11.2.2 Ecotrin Overview
11.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ecotrin Recent Developments
11.3 Generic
11.3.1 Generic Corporation Information
11.3.2 Generic Overview
11.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Generic Recent Developments
11.4 St. Joseph
11.4.1 St. Joseph Corporation Information
11.4.2 St. Joseph Overview
11.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 St. Joseph Recent Developments
11.5 Elanco
11.5.1 Elanco Corporation Information
11.5.2 Elanco Overview
11.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Elanco Recent Developments
11.6 Zoetis
11.6.1 Zoetis Corporation Information
11.6.2 Zoetis Overview
11.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zoetis Recent Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Corporation Information
11.7.2 Boehringer Ingelheim Overview
11.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Boehringer Ingelheim Recent Developments
11.8 Merial
11.8.1 Merial Corporation Information
11.8.2 Merial Overview
11.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merial Recent Developments
11.9 Merck Animal Health
11.9.1 Merck Animal Health Corporation Information
11.9.2 Merck Animal Health Overview
11.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck Animal Health Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain Analysis
12.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process
12.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Marketing
12.4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Channels
12.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors
12.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
13.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
13.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
13.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
14 Key Findings in The Global Non-steroidal Anti-inflammatory Drugs (NSAID) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Salicylates
Table 3. Major Manufacturers of Propionic acid derivatives
Table 4. Major Manufacturers of Acetic acid derivatives
Table 5. Major Manufacturers of Enolic acid (Oxicam) derivatives
Table 6. Major Manufacturers of Anthranilic acid derivatives (Fenamates)
Table 7. Major Manufacturers of Selective COX-2 inhibitors (Coxibs)
Table 8. Major Manufacturers of Sulfonanilides
Table 9. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 12. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2022)
Table 13. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2023-2028) & (K Units)
Table 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2023-2028)
Table 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2022)
Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2023-2028)
Table 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers (2017-2022)
Table 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2017-2022)
Table 23. Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Manufacturers (2017-2022) &(USD/Unit)
Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2021)
Table 26. Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered
Table 28. Date of Manufacturers Enter into Non-steroidal Anti-inflammatory Drugs (NSAID) Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 31. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 32. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2017-2022)
Table 33. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2023-2028)
Table 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2017-2022)
Table 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2023-2028)
Table 38. Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Type (2023-2028) & (USD/Unit)
Table 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 41. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2017-2022)
Table 43. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2023-2028)
Table 44. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2017-2022)
Table 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2023-2028)
Table 48. Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2022) & (USD/Unit)
Table 49. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Application (2023-2028) & (USD/Unit)
Table 50. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 51. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 52. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 55. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 56. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 59. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 60. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 63. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 64. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 67. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 68. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 71. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 72. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 75. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 76. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 79. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 80. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 83. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2023-2028) & (K Units)
Table 84. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 87. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 88. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 91. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 92. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 95. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 96. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 99. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 100. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 103. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 104. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 107. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 108. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (US$ Million)
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Major Businesses
Table 112. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bayer Recent Developments
Table 115. Ecotrin Corporation Information
Table 116. Ecotrin Description and Major Businesses
Table 117. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Ecotrin Recent Developments
Table 120. Generic Corporation Information
Table 121. Generic Description and Major Businesses
Table 122. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Generic Recent Developments
Table 125. St. Joseph Corporation Information
Table 126. St. Joseph Description and Major Businesses
Table 127. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. St. Joseph Recent Developments
Table 130. Elanco Corporation Information
Table 131. Elanco Description and Major Businesses
Table 132. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Elanco Recent Developments
Table 135. Zoetis Corporation Information
Table 136. Zoetis Description and Major Businesses
Table 137. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Zoetis Recent Developments
Table 140. Boehringer Ingelheim Corporation Information
Table 141. Boehringer Ingelheim Description and Major Businesses
Table 142. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Boehringer Ingelheim Recent Developments
Table 145. Merial Corporation Information
Table 146. Merial Description and Major Businesses
Table 147. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Merial Recent Developments
Table 150. Merck Animal Health Corporation Information
Table 151. Merck Animal Health Description and Major Businesses
Table 152. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Merck Animal Health Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
Table 158. Non-steroidal Anti-inflammatory Drugs (NSAID) Customers List
Table 159. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
Table 160. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
Table 161. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
Table 162. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Product Picture
Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type in 2021 & 2028
Figure 3. Salicylates Product Picture
Figure 4. Propionic acid derivatives Product Picture
Figure 5. Acetic acid derivatives Product Picture
Figure 6. Enolic acid (Oxicam) derivatives Product Picture
Figure 7. Anthranilic acid derivatives (Fenamates) Product Picture
Figure 8. Selective COX-2 inhibitors (Coxibs) Product Picture
Figure 9. Sulfonanilides Product Picture
Figure 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application in 2021 & 2028
Figure 11. Human
Figure 12. Animals
Figure 13. Others
Figure 14. Non-steroidal Anti-inflammatory Drugs (NSAID) Report Years Considered
Figure 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2017-2028 (K Units)
Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2017-2028 (US$ Million)
Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2022)
Figure 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2023-2028)
Figure 21. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2017-2028) & (K Units)
Figure 22. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2017-2028) & (K Units)
Figure 24. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2017-2028) & (K Units)
Figure 26. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2017-2028) & (K Units)
Figure 28. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2017-2028) & (K Units)
Figure 30. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) in the World: Market Share by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2021
Figure 33. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 38. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 39. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 40. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 41. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 42. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2017-2028)
Figure 43. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2017-2028)
Figure 44. U.S. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 47. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 48. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 49. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 50. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2017-2028)
Figure 51. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2017-2028)
Figure 52. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 53. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Region (2017-2028)
Figure 63. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 66. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 74. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 76. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2017-2028)
Figure 78. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2017-2028)
Figure 79. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2017-2028)
Figure 88. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 90. U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 91. Non-steroidal Anti-inflammatory Drugs (NSAID) Value Chain
Figure 92. Non-steroidal Anti-inflammatory Drugs (NSAID) Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.